Product Description
| Brand | Snibe |
| Sample Type | Serum |
| Pack Size | 100T |
| CAT No. | 130219016M |
| Application | Covid |
The kit has been designed for the qualitative determination of IgM antibodies against SARS-CoV-2 in human serum or plasma. The method can be used for samples within a measuring range of 0.110 COI. The test is performed on fully automated MAGLUMI chemiluminescence immunoassay (CLIA) analyzers, including MAGLUMI 800, MAGLUMI X8, and other MAGLUMI models such as MAGLUMI 1000, MAGLUMI 2000, MAGLUMI 2000 Plus, and MAGLUMI 4000.Advanced Chemiluminescence Immunoassay TechnologyLeveraging cutting-edge chemiluminescence immunoassay (CLIA) technology, the MAGLUMI COVID IGM kit delivers swift and reliable detection of COVID-19 IgM antibodies. This technology enhances sensitivity and specificity, supporting laboratories in providing trustworthy diagnostic outcomes.
Simple Integration with MAGLUMI AnalyzersThe reagent is purpose-built for seamless use with MAGLUMI CLIA analyzers, ensuring rapid real-time operation and optimized workflow in laboratory settings. This compatibility minimizes the chance of errors and maximizes testing throughput.
Compliant Storage and HandlingTo preserve reagent integrity, maintain storage temperatures between 2 and 8 degrees Celsius. This standard storage requirement ensures reagent longevity and consistent performance during diagnostic procedures, helping laboratories maintain quality control.
FAQ's of Snibe MAGLUMI COVID IGM (CLIA):
Q: How is the Snibe MAGLUMI COVID IGM (CLIA) reagent utilized in laboratory settings?
A: The MAGLUMI COVID IGM (CLIA) reagent is used with MAGLUMI CLIA analyzers to detect IgM antibodies against COVID-19 in human serum or plasma samples, enabling reliable identification of recent or ongoing infection.
Q: What technology underpins the Snibe MAGLUMI COVID IGM testing process?
A: This reagent employs chemiluminescence immunoassay (CLIA) technology, which combines sensitivity with high specificity, providing precise and trustworthy results for COVID-19 IgM antibody detection.
Q: When should the MAGLUMI COVID IGM (CLIA) reagent be used?
A: The reagent is best used when laboratory confirmation of a patient's COVID-19 IgM antibody status is required, such as during epidemiological investigations or for patient screening programs.
Q: Where can laboratories source the Snibe MAGLUMI COVID IGM (CLIA) reagent in India?
A: Laboratories in India can procure the reagent from authorized dealers, distributors, manufacturers, suppliers, traders, and wholesalers specializing in Snibe products and CLIA solutions.
Q: What is the correct storage procedure for these reagents?
A: Store the Snibe MAGLUMI COVID IGM (CLIA) reagents between 2 and 8 degrees Celsius in a refrigerator. Avoid freezing and exposure to direct sunlight to ensure reagent integrity.
Q: How does using this reagent benefit clinical laboratory operations?
A: Utilizing this reagent enhances operational efficiency by providing real-time results and accommodating high-throughput testing, which is crucial during pandemics. The compatibility with MAGLUMI analyzers also ensures smooth workflow integration.